Gene expression signatures modulated by epidermal growth factor receptor activation and their relationship to cetuximab resistance in head and neck squamous cell carcinoma

被引:18
作者
Fertig, Elana J. [1 ]
Ren, Qing [2 ]
Cheng, Haixia [1 ]
Hatakeyama, Hiromitsu [3 ]
Dicker, Adam P. [2 ,4 ]
Rodeck, Ulrich [2 ,5 ]
Considine, Michael [1 ]
Ochs, Michael F. [1 ,6 ]
Chung, Christine H. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA
[2] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19107 USA
[3] Hokkaido Univ, Sch Med, Dept Otolaryngol, Sapporo, Hokkaido 060, Japan
[4] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA
[5] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA
[6] Johns Hopkins Univ, Sch Med, Dept Hlth Sci Informat, Baltimore, MD 21205 USA
关键词
IMMORTALIZED HUMAN KERATINOCYTES; BAYESIAN-DECOMPOSITION; MICROARRAY DATA; PLUS CETUXIMAB; PHASE-II; CANCER; MUTATIONS; RECURRENT; PATTERNS; EGFR;
D O I
10.1186/1471-2164-13-160
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Aberrant activation of signaling pathways downstream of epidermal growth factor receptor (EGFR) has been hypothesized to be one of the mechanisms of cetuximab (a monoclonal antibody against EGFR) resistance in head and neck squamous cell carcinoma (HNSCC). To infer relevant and specific pathway activation downstream of EGFR from gene expression in HNSCC, we generated gene expression signatures using immortalized keratinocytes (HaCaT) subjected to ligand stimulation and transfected with EGFR, RELA/p65, or HRAS(Val12D). Results: The gene expression patterns that distinguished the HaCaT variants and conditions were inferred using the Markov chain Monte Carlo (MCMC) matrix factorization algorithm Coordinated Gene Activity in Pattern Sets (CoGAPS). This approach inferred gene expression signatures with greater relevance to cell signaling pathway activation than the expression signatures inferred with standard linear models. Furthermore, the pathway signature generated using HaCaT-HRAS(Val12D) further associated with the cetuximab treatment response in isogenic cetuximab-sensitive (UMSCC1) and -resistant (1CC8) cell lines. Conclusions: Our data suggest that the CoGAPS algorithm can generate gene expression signatures that are pertinent to downstream effects of receptor signaling pathway activation and potentially be useful in modeling resistance mechanisms to targeted therapies.
引用
收藏
页数:11
相关论文
共 46 条
[1]   Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 [J].
Agrawal, Nishant ;
Frederick, Mitchell J. ;
Pickering, Curtis R. ;
Bettegowda, Chetan ;
Chang, Kyle ;
Li, Ryan J. ;
Fakhry, Carole ;
Xie, Tong-Xin ;
Zhang, Jiexin ;
Wang, Jing ;
Zhang, Nianxiang ;
El-Naggar, Adel K. ;
Jasser, Samar A. ;
Weinstein, John N. ;
Trevino, Lisa ;
Drummond, Jennifer A. ;
Muzny, Donna M. ;
Wu, Yuanqing ;
Wood, Laura D. ;
Hruban, Ralph H. ;
Westra, William H. ;
Koch, Wayne M. ;
Califano, Joseph A. ;
Gibbs, Richard A. ;
Sidransky, David ;
Vogelstein, Bert ;
Velculescu, Victor E. ;
Papadopoulos, Nickolas ;
Wheeler, David A. ;
Kinzler, Kenneth W. ;
Myers, Jeffrey N. .
SCIENCE, 2011, 333 (6046) :1154-1157
[2]   Singular value decomposition for genome-wide expression data processing and modeling [J].
Alter, O ;
Brown, PO ;
Botstein, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (18) :10101-10106
[3]   Determination of strongly overlapping signaling activity from microarray data [J].
Bidaut, G ;
Suhre, K ;
Claverie, JM ;
Ochs, MF .
BMC BIOINFORMATICS, 2006, 7 (1)
[4]   Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].
Bonner, JA ;
Harari, PM ;
Giralt, J ;
Azarnia, N ;
Shin, DM ;
Cohen, RB ;
Jones, CU ;
Sur, R ;
Raben, D ;
Jassem, J ;
Ove, R ;
Kies, MS ;
Baselga, J ;
Youssoufian, H ;
Amellal, N ;
Rowinsky, EK ;
Ang, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578
[5]  
BOUKAMP P, 1990, CANCER RES, V50, P2840
[6]   NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE [J].
BOUKAMP, P ;
PETRUSSEVSKA, RT ;
BREITKREUTZ, D ;
HORNUNG, J ;
MARKHAM, A ;
FUSENIG, NE .
JOURNAL OF CELL BIOLOGY, 1988, 106 (03) :761-771
[7]  
BREITKREUTZ D, 1991, CANCER RES, V51, P4402
[8]   Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression [J].
Chung, CH ;
Parker, JS ;
Karaca, G ;
Wu, JY ;
Funkhouser, WK ;
Moore', D ;
Butterfoss, D ;
Xiang, D ;
Zonation, A ;
Yin, XY ;
Shockley, WW ;
Weissler, MC ;
Dressler, LG ;
Shores, CG ;
Yarbrough, WG ;
Perou, CM .
CANCER CELL, 2004, 5 (05) :489-500
[9]   Gene expression profiles as markers of aggressive disease-EGFR as a factor [J].
Chung, Christine H. ;
Parker, Joel ;
Levy, Shawn ;
Slebos, Robbert J. ;
Dicker, Adam P. ;
Rodeck, Ulrich .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (02) :S102-S105
[10]   Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck [J].
Cohen, EEW ;
Rosen, F ;
Stadler, WM ;
Recant, W ;
Stenson, K ;
Huo, DZ ;
Vokes, EE .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (10) :1980-1987